NasdaqCM - Delayed Quote USD
Alzamend Neuro, Inc. (ALZN)
3.8300
-1.6100
(-29.60%)
At close: May 30 at 4:00:02 PM EDT
3.9600
+0.13
+(3.39%)
After hours: May 30 at 7:59:48 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 2 |
| Avg. Estimate | -2.7 | -3.69 | -11.88 | -10.98 |
| Low Estimate | -2.7 | -3.69 | -11.88 | -15.21 |
| High Estimate | -2.7 | -3.69 | -11.88 | -6.75 |
| Year Ago EPS | -120.15 | -11.25 | -132.3 | -11.88 |
Revenue Estimate
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 1 | 2 | 2 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 4/30/2024 | 7/31/2024 | 10/31/2024 | 1/31/2025 |
|---|---|---|---|---|
| EPS Est. | -34.2 | -21.42 | -3.42 | -3.19 |
| EPS Actual | -120.15 | -11.25 | -3.6 | -1.71 |
| Difference | -85.95 | 10.17 | -0.18 | 1.48 |
| Surprise % | -251.32% | 47.48% | -5.26% | 46.48% |
EPS Trend
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -2.7 | -3.69 | -11.88 | -10.98 |
| 7 Days Ago | -4.05 | -3.96 | -16.11 | -11.07 |
| 30 Days Ago | -4.05 | -3.96 | -15.12 | -15.39 |
| 60 Days Ago | -4.05 | -3.96 | -15.12 | -15.39 |
| 90 Days Ago | -4.05 | -3.96 | -15.12 | -15.39 |
EPS Revisions
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 1 | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ALZN | 97.75% | 67.20% | 91.02% | 7.58% |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.96% |
Upgrades & Downgrades
| Maintains | Ascendiant Capital: Buy to Buy | 3/17/2025 |
| Maintains | Ascendiant Capital: Buy to Buy | 12/16/2024 |
| Maintains | Ascendiant Capital: Buy to Buy | 11/11/2024 |
Related Tickers
SPRO Spero Therapeutics, Inc.
2.5000
+17.37%
BLRX BioLineRx Ltd.
5.25
+35.31%
ASBP Aspire Biopharma Holdings, Inc.
0.4301
-28.60%
IMNN Imunon, Inc.
2.4900
+25.13%
PLRZ Polyrizon Ltd.
0.9131
-26.95%
ORIC ORIC Pharmaceuticals, Inc.
8.17
+2.51%
INAB IN8bio, Inc.
0.1482
-3.39%
TNXP Tonix Pharmaceuticals Holding Corp.
39.78
-5.33%
VERU Veru Inc.
0.5082
-0.20%
RCKT Rocket Pharmaceuticals, Inc.
2.5100
-4.20%